These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 18518837)
1. The relevance of animal models for aerosol studies. Phalen RF; Oldham MJ; Wolff RK J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):113-24. PubMed ID: 18518837 [TBL] [Abstract][Full Text] [Related]
2. Pediatric in vitro and in silico models of deposition via oral and nasal inhalation. Carrigy NB; Ruzycki CA; Golshahi L; Finlay WH J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):149-69. PubMed ID: 24870701 [TBL] [Abstract][Full Text] [Related]
3. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles. Oberdorster G Inhal Toxicol; 1996; 8 Suppl():73-89. PubMed ID: 11542496 [TBL] [Abstract][Full Text] [Related]
4. Inspiratory and expiratory aerosol deposition in the upper airway. Verbanck S; Kalsi HS; Biddiscombe MF; Agnihotri V; Belkassem B; Lacor C; Usmani OS Inhal Toxicol; 2011 Feb; 23(2):104-11. PubMed ID: 21309663 [TBL] [Abstract][Full Text] [Related]
5. Incorporation of particle size differences between animal studies and human workplace aerosols for deriving exposure limit values. Oller AR; Oberdörster G Regul Toxicol Pharmacol; 2010; 57(2-3):181-94. PubMed ID: 20172011 [TBL] [Abstract][Full Text] [Related]
6. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422 [TBL] [Abstract][Full Text] [Related]
7. Determining the basic characteristics of aerosols suitable for studies of deposition in the respiratory tract. Legáth L; Naus A; Halík J J Hyg Epidemiol Microbiol Immunol; 1988; 32(3):287-97. PubMed ID: 3198910 [TBL] [Abstract][Full Text] [Related]
8. The impact of pulmonary diseases on the fate of inhaled medicines--a review. Wang YB; Watts AB; Peters JI; Williams RO Int J Pharm; 2014 Jan; 461(1-2):112-28. PubMed ID: 24291124 [TBL] [Abstract][Full Text] [Related]
9. [Mechanisms of the therapeutic and damaging (side effects) actions of inhalation aerosol therapy]. Pilipchuk NS; Kliachkin LM; Protsiuk RG Vopr Kurortol Fizioter Lech Fiz Kult; 1989; (1):21-4. PubMed ID: 2652880 [TBL] [Abstract][Full Text] [Related]
10. In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols. Byron PR; Hindle M; Lange CF; Longest PW; McRobbie D; Oldham MJ; Olsson B; Thiel CG; Wachtel H; Finlay WH J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S59-69. PubMed ID: 21133801 [TBL] [Abstract][Full Text] [Related]
11. Insights on animal models to investigate inhalation therapy: Relevance for biotherapeutics. Guillon A; Sécher T; Dailey LA; Vecellio L; de Monte M; Si-Tahar M; Diot P; Page CP; Heuzé-Vourc'h N Int J Pharm; 2018 Jan; 536(1):116-126. PubMed ID: 29180257 [TBL] [Abstract][Full Text] [Related]